Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies
{{output}}
Background: The immunogenicity and limited stability of conventional messenger RNA (mRNA) has traditionally restricted its potential therapeutic use. In 1992, the first clinical application of mRNA was reported as a potential pro... ...
